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Abstract
Erythropoietin (Epo) is one of the physiologically important genes whose transcription is up-regulated by hypoxia. Our
laboratory previously proposed that the sensor of this event is a heme protein which turns over rapidly. We have investigated
the effects of four inhibitors of heme synthesis (4,6-dioxoheptanoic acid (DHA), isoniazid (INH), N-methyl protoporphyrin
IX (MPP), and deferoxamine mesylate (DSF)) on hypoxia-, cobalt-, and DSF-induced erythropoietin (Epo) mRNA
expression, heme biosynthesis, and cell viability in Hep3B cells. DHA (0.1^1.0 mM) inhibited heme biosynthesis more than
85%, but did not suppress Epo mRNA expression. Epo mRNA expression was inhibited only at higher concentrations of
DHA (2, 4 mM) which also inhibited cell viability. No suppression of Epo mRNA expression by INH was observed at doses
known to inhibit heme biosynthesis. MPP did not suppress Epo mRNA expression although it showed an inhibitory effect on
heme biosynthesis without any decreased cell viability. 130 WM DSF, a dose which inhibited heme biosynthesis without cell
toxicity, suppressed hypoxia-induced Epo mRNA expression, but enhanced cobalt-induced Epo mRNA expression. These
results show that although the oxygen sensor is probably a heme protein it does not turn over rapidly. Therefore, cobalt is
unlikely to act by substituting for heme iron. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Almost all living organisms from bacteria to hu-
man beings utilize oxygen in order to acquire e⁄cient
chemical energy. Therefore, the survival of cells and
organisms depends upon some type of sensitive oxy-
gen sensing system. In fact a number of physiologi-
cally important genes are induced by hypoxia. These
include erythropoietin (Epo), tyrosine hydroxylase,
vascular endothelial growth factor, and genes in-
volved in glucose metabolism [1]. Currently there is
considerable interest in the mechanism of oxygen
sensing and transduction of signal that e¡ects expres-
sion of these and other oxygen responsive genes.
Epo, a glycoprotein hormone produced in the kid-
ney and liver, regulates erythrocyte production. Epo
production is strongly induced not only by hypoxia,
but also by certain divalent metals including cobalt
(Co2), nickel, and manganese. The expression of
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Epo in human hepatoma cell lines such as Hep3B cells
or HepG2 cells [2] has frequently been used as an
e¡ective model for studying the oxygen sensor. Gold-
berg et al. [3] have proposed that oxygen is sensed by
binding to a heme protein with a resulting change in
conformation. In oxygenated cells, the oxy form does
not stimulate Epo induction whereas, at low oxygen
tension, the deoxy form triggers increased expression
of the Epo gene. In this model, the ability of cobalt to
simulate hypoxia was explained by the substitution of
Co2 for ferrous iron in the porphyrin ring, thereby
locking the heme protein in the deoxy conformation
just as at low oxygen tension.
This heme protein model was supported by evidence
that two heme synthesis inhibitors, 4,6-dioxohepta-
noic acid (DHA, succinylacetone) and deferoxamine
mesylate (DSF), reduced hypoxia- or Co2-induced
Epo induction in Hep3B cells [3]. DHA is a potent
and speci¢c inhibitor of N-aminolevulinic acid (ALA)
dehydratase, the enzyme which converts two mole-
cules of ALA to porphobilinogen. However, the con-
centration of DHA that was used (2 mM) is consider-
ably higher than that previously shown to inhibit ALA
dehydratase activity and heme biosynthesis [4^6].
Therefore, the reduced Epo production in Hep3B cells
treated with DHA reported by Goldberg et al. might
be due to a toxic e¡ect on cells rather than its inhib-
itory e¡ect on heme biosynthesis. In fact, Srinivas et
al. [7] recently reported that DHA, at a concentration
su⁄cient to inhibit heme synthesis, failed to blunt hy-
poxic induction of a reporter gene. In order to resolve
this issue it is necessary to develop dose^response re-
lationships to determine the impact of heme synthesis
inhibitors on Epo induction versus cell viability. In
this paper we tested not only DHA but also three addi-
tional heme synthesis inhibitors: isoniazid (INH), N-
methyl protoporphyrin IX (MPP) and DSF, and have
monitored the e¡ects of these inhibitors on Epo
mRNA expression, heme biosynthesis and cell viabil-
ity in Hep3B cells.
2. Materials and methods
2.1. Cell culture
Hep3B cells were maintained in K-modi¢ed Eagle’s
medium (Gibco BRL) supplemented with 10% fetal
bovine serum (Gibco BRL) at 37‡C. At the initiation
of each experiment, cells were resuspended in the me-
dium at a density of 2.5U105/ml and after preincuba-
tion for 24 h, heme synthesis inhibitors, DHA, INH,
DSF and MPP were added and the incubation was
continued for another 24 h. DHA, INH and DSF
were purchased from Sigma, and MPP was obtained
from Porphyrin Products. Cells were cultured either
under normoxic conditions (95% air and 5% CO2), or,
in some experiments, were exposed to hypoxia (1% O2,
94% N2, and 5% CO2) in an Espec BNP-210 incuba-
tor.
2.2. Ribonuclease protection analysis
We used a previously described [8] construct
(pGRm) in which a 203 bp long DNA fragment of
genomic human Epo (GenBank accession number
M11319, nucleotides 2565^2767) was inserted into
pGEM3Zf(+). The Epo gene in this construct has
been ‘marked’ by site-directed mutagenesis at three
positions in the coding region of Exon 5 [8]. As a
result, after hybridization of this marked riboprobe
to endogenous Epo mRNA, RNase digestion yields
two major fragments of 75 bp and 61 bp. RNA was
puri¢ed from Hep3B cells by using TRI ZOL Re-
agent (Gibco BRL). The concentrations of total
RNA was calculated by measuring the absorbance
at 260 nm and 280 nm. The intactness of each
RNA sample was con¢rmed by visualization on a
UV transilluminator after running small aliquots on
a 1% agarose gel. Sixty Wg of each RNA sample was
mixed with Epo riboprobe labeled by K-[32P]CTP
(NEN) and hybridized at 55‡C overnight. The hy-
bridized RNAs were digested by RNase and electro-
phoresed in 10% polyacrylamide gel as described pre-
viously [8]. The dried gel was analyzed by a
phosphoimager (Molecular Dynamics).
2.3. Assay of heme biosynthesis
The newly synthesized heme in Hep3B cells was
measured as described by Shedlofsky et al. [9]. After
preincubation in 3.5-cm culture dishes, Hep3B cells
were further incubated for 24 h with the heme pre-
cursor N-[14C]ALA (NEN) (0.2 WCi/dish). Cold
N-ALA (20 WM) was also added to the culture medium
as the carrier for N-[14C]ALA. At the end of incu-
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bation, the total heme was extracted from the cells by
using acetone^HCl and diethyl ether. With the ex-
ception of experiments testing the e¡ects of INH,
the incorporation of radioactivity into the extracted
heme provided a measure of heme biosynthesis.
2.4. Cell viability assay
We used a modi¢ed MTT (3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyl tetrazolium bromide) assay for
evaluating cell viability [10]. One-tenth volume of
MTT solution (Sigma) was added to the media of
cultured cells and incubated at 37‡C for 1 h. At the
end of incubation period the media was removed
from the culture plate and the converted dye was
solubilized with DMSO. Cell viability was deter-
mined from the absorbance of the dye at 570 nm
with background subtraction at 630 nm.
3. Results
We treated Hep3B cells for 24 h in a normoxic
atmosphere with four types of heme synthesis inhib-
itors, DHA, INH, MPP and DSF. We then cultured
the cells under either hypoxia, or in the presence of
100 WM Co2, or 130 WM DSF for 6 h. We deter-
mined Epo mRNA expression in these cells by ribo-
nuclease protection assay (RPA) and measured heme
biosynthesis and viability of the cells.
3.1. DHA
As shown in Fig. 1A, 100 WM and 1 mM of DHA
inhibited heme biosynthesis in Hep3B cells more
than 85%, consistent with previous reports [4^6].
However, 1 mM of DHA suppressed hypoxia-,
Co2- and DSF-induced Epo mRNA expression by
no more than 20% (Fig. 1B). We observed strong
diminution of Epo mRNA expression by DHA
only at higher concentrations (2 and 4 mM). This
result is also consistent with previously reported re-
sults on the inhibition of Epo production, assayed by
RIA, at 2 mM DHA [3]. However, cell viability was
clearly decreased at these higher doses of DHA by
morphologic observation (not shown) as well as by
MTT assay (Fig. 1C). These results indicate that the
suppression of Epo mRNA induction by DHA at
2 mM was not due to inhibition of heme biosynthe-
sis, but rather to cell toxicity.
3.2. INH
INH inhibits pyridoxal phosphate, an essential co-
Fig. 1. E¡ect of DHA on heme biosynthesis (A), Epo mRNA
induction (B) and cell viability (C). Hep3B cells were treated
with 4,6-dioxoheptanoic acid (DHA) at the indicated doses of
DHA for 24 h followed by a 6-h exposure to either hypoxia
(1% O2), 100 mM cobalt (Co2), or 130 mM deferoxamine me-
sylate (DSF). Heme synthesis was measured by incorporation
of [14C]ALA into heme. RNase protection assay was performed
to show the two bands of protected Epo mRNA at 75 bp and
61 bp. Results in panel B are representative of three indepen-
dent experiments. The data in panels A and C are expressed as
mean þ S.D. of three independent experiments.
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factor of ALA synthase. In rabbit reticulocytes,
1 mM INH causes a 70% suppression of incorpora-
tion of 59Fe into heme [11]. In Hep3B cells, 1^20 mM
INH had no e¡ect on the induction of Epo mRNA
by hypoxia, cobalt or DSF (Fig. 2B). Because of its
site of inhibition, INH would not be expected to
a¡ect the incorporation of [14C]ALA into heme.
The modest suppression which we observed at high
concentrations of INH (10, 20, 50 mM) (Fig. 2A) is
probably a non-speci¢c toxic e¡ect since cell viability
was also impaired to about the same extent (Fig.
2C).
3.3. MPP
MPP is a powerful inhibitor of ferrochelatase, the
¢nal enzyme in the heme biosynthetic pathway, cat-
alyzing the insertion of ferrous iron into protopor-
phyrin IX to form protoheme [12,13]. As shown in
Fig. 3, in Hep3B cells, MPP, at concentrations rang-
ing from 0.05 Wg/ml up to 5 Wg/ml (0.09^9 WM), had
a dose-dependent inhibitory e¡ect on heme biosyn-
thesis without any cell toxicity. Even at 80% inhibi-
tion observed with the highest dose (5 Wg/ml), MPP
had no e¡ect on cell viability or on induction of Epo
Fig. 3. E¡ect of MPP on heme biosynthesis (A), Epo mRNA
induction (B) and cell viability (C). Cells were treated with
MPP at the indicated doses for 24 h. Experimental conditions
were as described in the legend to Fig. 1.
Fig. 2. E¡ect of INH on the incorporation of [14C]ALA into
heme (A), Epo mRNA induction (B) and cell viability (C).
Cells were treated with isoniazid at the indicated doses for 24
h. Experimental conditions were as described in the legend to
Fig. 1.
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mRNA by hypoxia, Co2 or DSF. These results
again show that Epo can be robustly induced despite
strong inhibition of heme biosynthesis.
3.4. DSF
DSF, an iron-chelating agent, is an inducer of Epo
[14]. DSF is also an inhibitor of heme synthesis, pre-
venting protoporphyrin from being converted to
heme by removing the iron that is normally incorpo-
rated into the porphyrin ring [15,16]. DSF showed
dose-dependent inhibition of heme biosynthesis (Fig.
4A) without obvious cell toxicity (Fig. 4C). At the
highest concentration tested (130 WM), DSF inhib-
ited hypoxia-induced Epo mRNA expression by
about 80% (Fig. 4B), consistent with earlier measure-
ments of Epo protein [2]. However, DSF had no
e¡ect on the induction of Epo mRNA by cobalt.
4. Discussion
In these experiments, Epo mRNA was monitored
as an index of cellular response to hypoxia. This
induction of Epo mRNA depends on an intact and
functional oxygen sensing and signaling pathway.
We have investigated the role of heme synthesis in
this process by using four compounds having di¡er-
ent inhibitory mechanisms. We could not observe
any relationship between suppression of Epo induc-
tion and heme biosynthesis inhibition. We previously
reported that a heme synthesis inhibitor, DHA, re-
duced hypoxia- and Co2-induced Epo production in
Hep3B cells [3]. However, in Fig. 1 we present evi-
dence that DHA suppresses Epo induction by virtue
of cell toxicity rather than through inhibition of
heme synthesis.
Among the four heme inhibitors, only DSF
showed a dose-dependent suppressive e¡ect on hyp-
oxia-induced Epo mRNA expression with intact cell
viability. In contrast, MPP, which, like DSF, blocks
conversion of protoporphyrin to heme, had no e¡ect
on Epo induction. Because DSF has contradictory
e¡ects on Epo induction by hypoxia versus cobalt,
interpretation of this result is di⁄cult. Through che-
lating iron, DSF can a¡ect not only heme synthesis
but also Fenton chemistry which is thought to play
an important role in hypoxic signaling, upon which
Epo induction depends [1]. Our ¢nding that DSF
suppresses hypoxic induction of Epo but has no ef-
fect on Co2 induction is di⁄cult to reconcile with
recent models of oxygen sensing and signal transduc-
tion.
In 1988, Goldberg et al. proposed that Co2 and
other transition metals (Ni2 and Mn2) induced
Epo expression by substituting for the iron atom in
a heme protein which they proposed to be the oxy-
gen sensor. This suggestion was based on the fact
that these substituted metalloporphyrins either have
a very low a⁄nity for oxygen (Co2-heme) or fails to
bind oxygen at all (Ni2-heme, Mn2-heme). This
Fig. 4. E¡ect of DSF on heme biosynthesis (A), Epo mRNA
induction (B) and cell viability (C). Cells were treated with
DSF at the indicated doses for 24 h. Experimental conditions
were as described in the legend to Fig. 1.
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proposed mechanism for the induction of Epo by
these transition metals implies, and, in fact, requires,
that the heme protein oxygen sensor turns over very
quickly to enable the Co2-heme (or Ni2-heme and
Mn2-heme) to fully replace the Fe2-heme. The fact
that inhibition of heme synthesis fails to suppress
Epo induction argues strongly that the postulated
heme protein oxygen sensor turns over relatively
slowly and therefore Co2, Ni2 and Mn2 do not
function by substituting for the heme iron. It is far
more likely that these transition metals act by sup-
pressing O2 and Fe2 catalyzed oxidation of a pro-
tein involved in the signaling pathway ([17,18]; W.
Willmore, H.F. Bunn, unpublished observations).
Our results provide insight into the mechanism by
which certain transition metals such as Co2 mimic
hypoxia, but they in no way negate the contention
that the oxygen sensor is a heme protein. The fact
that nitric oxide [19^21] and carbon monoxide, at
high concentration [3,20,21], suppresses hypoxic in-
duction of Epo and the hypoxia-inducible transcrip-
tion factor HIF-1 is consistent with the oxygen sen-
sor being a heme protein.
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